skin wart. Viral warts
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with skin wart who are diagnosed by a dermatologist clinically or pathologically and have cryotherapy indications. Patients over 2 years of age They have a conscious consent to enter the study the maximum number of warts is up to 20
Exclusion criteria
Exclusion criteria: pregnant and lactating women People treated with systemic medications that interfere with wound healing or immuno suppressive drugs Patients who have contraindications for cryotherapy Patients who have used topical medications other than emollients in the past month People who are allergic to betamethasone or topical steroids Patients with wound healing disorders such as diabetes Distributed and resistant warts that need further treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tolerance of pain to cryotherapy treatment. Timepoint: Day 1,7 and 14. Method of measurement: Vas scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Illness severity. Timepoint: At the beginning of the study. Method of measurement: Based on the number of warts.;Duration of illness. Timepoint: At the beginning of the study. Method of measurement: Number of days before starting treatment.;Eritrea. Timepoint: The second, eighth and fifteenth day after starting treatment. Method of measurement: Based on the examination.;Blisters. Timepoint: The second, eighth and fifteenth day after starting treatment. Method of measurement: Based on the examination.;Scar. Timepoint: The second, eighth and fifteenth day after starting treatment. Method of measurement: Based on the examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Mazandaran University of Medical Sciences